Holen Sie sich die Stockscreener-App
1.31
1.95%
0.025
Handel nachbörslich:
1.31
Schlusskurs vom Vortag:
$1.285
Offen:
$1.27
24-Stunden-Volumen:
132.94K
Relative Volume:
0.17
Marktkapitalisierung:
$24.98M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-11.24M
KGV:
-1.7203
EPS:
-0.7615
Netto-Cashflow:
$-4.79M
1W Leistung:
+0.00%
1M Leistung:
-9.66%
6M Leistung:
+47.19%
1J Leistung:
+22.43%
1-Tages-Spanne:
$1.25
$1.33
1-Wochen-Bereich:
$1.25
$1.37
52-Wochen-Spanne:
$0.73
$2.56
Mira Pharmaceuticals Inc Stock (MIRA) Company Profile
Firmenname
Mira Pharmaceuticals Inc
Sektor
Telefon
813-369-5150
Adresse
1200 BRICKELL AVENUE, MIAMI
Vergleichen Sie MIRA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MIRA
Mira Pharmaceuticals Inc
|
1.31 | 24.50M | 0 | -11.24M | -4.79M | -0.7615 |
|
LLY
Lilly Eli Co
|
812.35 | 734.56B | 53.26B | 13.80B | -50.20M | 15.08 |
|
JNJ
Johnson Johnson
|
190.85 | 459.75B | 90.62B | 22.66B | 18.18B | 9.35 |
|
ABBV
Abbvie Inc
|
229.13 | 406.84B | 58.33B | 3.73B | 18.24B | 2.1013 |
|
NVS
Novartis Ag Adr
|
130.26 | 249.96B | 53.40B | 13.68B | 16.89B | 6.8864 |
|
MRK
Merck Co Inc
|
84.70 | 214.06B | 63.43B | 16.42B | 14.72B | 6.4861 |
Mira Pharmaceuticals Inc Aktie (MIRA) Neueste Nachrichten
Published on: 2025-10-13 23:42:35 - newser.com
MIRA Pharmaceuticals Announces Favorable Topline Results from Phase 1 SAD Study of Oral Ketamir-2, a Next-Generation Non-Scheduled Ketamine Analog - GoUpstate
How to monitor MIRA Pharmaceuticals Inc. with trend dashboardsRisk Management & Daily Growth Stock Tips - newser.com
How to manage a losing position in MIRA Pharmaceuticals Inc.Weekly Trend Recap & Community Trade Idea Sharing - newser.com
Trend analysis for MIRA Pharmaceuticals Inc. this week2025 Volatility Report & Proven Capital Preservation Tips - newser.com
Is MIRA Pharmaceuticals Inc. stock a contrarian buy2025 EndofYear Setup & Safe Capital Investment Plans - newser.com
Published on: 2025-10-13 08:57:32 - newser.com
Price momentum metrics for MIRA Pharmaceuticals Inc. explainedWeekly Trade Recap & Community Verified Trade Signals - newser.com
Should you wait for a breakout in MIRA Pharmaceuticals Inc.2025 Technical Overview & Smart Investment Allocation Tips - newser.com
Can MIRA Pharmaceuticals Inc. stock surprise with earnings upsideFed Meeting & High Accuracy Swing Entry Alerts - newser.com
MIRA Pharmaceuticals reports positive in vitro drug release data for topical Ketamir-2 - MSN
What drives MIRA Pharmaceuticals Inc stock priceStock Price Targets & Budget Investment Success - earlytimes.in
Is MIRA Pharmaceuticals Inc. stock a buy in volatile marketsMarket Sentiment Report & Technical Pattern Alert System - newser.com
MIRA Pharmaceuticals Inc. stock daily chart insightsPortfolio Profit Report & Precise Swing Trade Alerts - newser.com
What machine learning models say about MIRA Pharmaceuticals Inc.Weekly Risk Summary & Proven Capital Preservation Tips - newser.com
MIRA Pharmaceuticals Inc Stock Analysis and ForecastTechnical Resistance Breaks & Free Hedging Tactics for Volatile Markets - earlytimes.in
Published on: 2025-10-09 04:14:21 - newser.com
Is MIRA Pharmaceuticals Inc. reversing from oversold territory2025 EndofYear Setup & Precise Swing Trade Alerts - newser.com
What analysts say about MIRA Pharmaceuticals Inc stockEquity Performance Review & Low Cost Trading Plans - earlytimes.in
What indicators show strength in MIRA Pharmaceuticals Inc.Market Performance Recap & AI Optimized Trading Strategy Guides - newser.com
MIRA Pharmaceuticals Reports New Topical Ketamir-2 shows comparable effects to Injected Morphine in Preclinical Pain Study - Fall River Herald News
Is MIRA Pharmaceuticals Inc. a candidate for recovery playPortfolio Return Report & Low Risk High Win Rate Picks - newser.com
MIRA Pharmaceuticals Reports Positive PTSD Data Demonstrating Ketamir-2 Restores Normalized Behavior in Stressed Animals - El Paso Times
What data driven models say about MIRA Pharmaceuticals Inc.’s futureWeekly Profit Analysis & Consistent Growth Equity Picks - newser.com
Can MIRA Pharmaceuticals Inc. stock sustain free cash flow growth2025 Top Gainers & Fast Gaining Stock Reports - newser.com
Using fundamentals and technicals on MIRA Pharmaceuticals Inc.Market Activity Report & Fast Moving Stock Watchlists - newser.com
Analyzing MIRA Pharmaceuticals Inc. with multi timeframe chartsJuly 2025 Short Interest & Technical Entry and Exit Tips - newser.com
MIRA Pharmaceuticals (NASDAQ:MIRA) Stock Rating Upgraded by Wall Street Zen - Defense World
MIRA Pharmaceuticals Closes Acquisition of SKNY Pharmaceuticals, Expands Pipeline with SKNY-1 for Obesity and Nicotine Addiction - The Oklahoman
Custom strategy builders for tracking MIRA Pharmaceuticals Inc.July 2025 Fed Impact & Fast Entry High Yield Stock Tips - newser.com
MIRA Pharmaceuticals Completes SKNY Acquisition - MSN
What moving averages say about MIRA Pharmaceuticals Inc.New Guidance & Free Safe Entry Trade Signal Reports - newser.com
MIRA Pharmaceuticals completes acquisition of SKNY Pharmaceuticals By Investing.com - Investing.com Nigeria
MIRA Pharmaceuticals Closes Acquisition of SKNY Pharmaceuticals - citybiz
Mira Pharmaceuticals completes acquisition of SKNY Pharmaceuticals By Investing.com - Investing.com Nigeria
MIRA Pharmaceuticals completes acquisition of SKNY Pharmaceuticals - Investing.com
Finanzdaten der Mira Pharmaceuticals Inc-Aktie (MIRA)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.86%
0.85%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):